Literature DB >> 10734041

Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway.

A Papapetropoulos1, D Fulton, K Mahboubi, R G Kalb, D S O'Connor, F Li, D C Altieri, W C Sessa.   

Abstract

A productive angiogenic response must couple to the survival machinery of endothelial cells to preserve the integrity of newly formed vessels. Angiopoietin-1 (Ang-1) is an endothelium-specific ligand essential for embryonic vascular stabilization, branching morphogenesis, and post-natal angiogenesis, but its contribution to endothelial cell survival has not been completely elucidated. Here we show that Ang-1 acting via the Tie 2 receptor induces phosphorylation of the survival serine-threonine kinase, Akt (or protein kinase B). This is associated with up-regulation of the apoptosis inhibitor, survivin, in endothelial cells and protection of endothelium from death-inducing stimuli. Moreover, dominant negative survivin negates the ability of Ang-1 to protect cells from undergoing apoptosis. The activation of anti-apoptotic pathways mediated by Akt and survivin in endothelial cells may contribute to Ang-1 stabilization of vascular structures during angiogenesis, in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734041     DOI: 10.1074/jbc.275.13.9102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  170 in total

1.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

Authors:  J Llevadot; S Murasawa; Y Kureishi; S Uchida; H Masuda; A Kawamoto; K Walsh; J M Isner; T Asahara
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2.

Authors:  Shai Y Schubert; Alejandro Benarroch; Juan Monter-Solans; Elazer R Edelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-27       Impact factor: 8.311

3.  Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment.

Authors:  Hanako Kobayashi; Laura M DeBusk; Yael O Babichev; Daniel J Dumont; Pengnian Charles Lin
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

4.  PKB phosphorylation and survivin expression are cooperatively regulated by disruption of microfilament cytoskeleton.

Authors:  Yu-Long Liang; Li-Ying Wang; Heng Wu; Dong-Zhu Ma; Zhen Xu; Xi-Liang Zha
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 5.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

6.  Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Authors:  Hodan Ismail; Mahroo Mofarrahi; Raquel Echavarria; Sharon Harel; Eric Verdin; Hyung W Lim; Zheng-Gen Jin; Jianxin Sun; Huiyan Zeng; Sabah N A Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

Review 7.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

8.  Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish.

Authors:  In Hye Jung; Ga Lam Leem; Dawoon E Jung; Min Hee Kim; Eun Young Kim; Se Hoon Kim; Hae-Chul Park; Seung Woo Park
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

9.  VE-statin, an endothelial repressor of smooth muscle cell migration.

Authors:  Fabrice Soncin; Virginie Mattot; Frédéric Lionneton; Nathalie Spruyt; Frédéric Lepretre; Agnès Begue; Dominique Stehelin
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.

Authors:  Masaaki Hayashi; Sung-Woo Kim; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; E Dale Abel; Brian Eliceiri; Young Yang; Richard J Ulevitch; Jiing-Dwan Lee
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.